Drug Shortage Report for VIOKACE

Last updated on 2019-07-13 History
Report ID 87801
Drug Identification Number 02230019
Brand name VIOKACE
Common or Proper name Viokace 10440
Company Name APTALIS PHARMA CANADA ULC
Active Ingredient(s) AMYLASE PROTEASE LIPASE
Strength(s) 56400UNIT 57100UNIT 10440UNIT
Dosage form(s) TABLET
Route of administration ORAL
Packaging size 100's bottle
ATC code A09AA
ATC description DIGESTIVES, INCL ENZYMES
Reason for shortage Demand increase for the drug.
Anticipated start date 2019-07-12
Actual start date
Estimated end date 2019-08-05
Actual end date
Shortage status Actual shortage
Updated date 2019-07-13
Company comments Viokace 20880 remains in stock and available
Health Canada comments
Company contact information Company contact information; Telephone number: 800-668-6424 Email address: MR-GENERAL_INQUIRY@allergan.com Website address: allergan.ca Postal address: 500-85 Enterprise Blvd, Markham, Ontario, L6G 0B5

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v7 2019-07-13 English Compare
v6 2019-07-05 French Compare
v5 2019-07-05 English Compare
v4 2019-06-28 French Compare
v3 2019-06-28 English Compare
v2 2019-06-28 French Compare
v1 2019-06-28 English Compare